Nothing Special   »   [go: up one dir, main page]

ATE283277T1 - Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration - Google Patents

Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration

Info

Publication number
ATE283277T1
ATE283277T1 AT98908308T AT98908308T ATE283277T1 AT E283277 T1 ATE283277 T1 AT E283277T1 AT 98908308 T AT98908308 T AT 98908308T AT 98908308 T AT98908308 T AT 98908308T AT E283277 T1 ATE283277 T1 AT E283277T1
Authority
AT
Austria
Prior art keywords
viruses
nanofiltration
removal
log
protein solutions
Prior art date
Application number
AT98908308T
Other languages
English (en)
Inventor
Harry Hiemstra
Hart Hendricus Gerardus Jo Ter
Nijs Ingrid Margareth Prins-De
Pieter Johannes Hoek
Jan Over
Original Assignee
Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26146172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE283277(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanquin Bloedvoorziening filed Critical Sanquin Bloedvoorziening
Application granted granted Critical
Publication of ATE283277T1 publication Critical patent/ATE283277T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Water Supply & Treatment (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT98908308T 1997-02-24 1998-02-23 Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration ATE283277T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL1005332 1997-02-24
EP97200533A EP0860444A1 (de) 1997-02-24 1997-02-24 Methode zur Entfernung von Viren aus Proteinlösungen
PCT/NL1998/000108 WO1998037086A1 (en) 1997-02-24 1998-02-23 Method for removing viruses from protein solution by nanofiltration

Publications (1)

Publication Number Publication Date
ATE283277T1 true ATE283277T1 (de) 2004-12-15

Family

ID=26146172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98908308T ATE283277T1 (de) 1997-02-24 1998-02-23 Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration

Country Status (6)

Country Link
EP (2) EP0860444A1 (de)
AT (1) ATE283277T1 (de)
DE (1) DE69827787T2 (de)
DK (1) DK0979237T3 (de)
ES (1) ES2229481T3 (de)
WO (1) WO1998037086A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
WO2001045719A1 (fr) * 1999-12-20 2001-06-28 Mitsubishi Pharma Corporation Compositions a base de proteines de plasma exemptes de virus traitees a l'aide d'une membrane poreuse et procede de production
ES2214967B1 (es) 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
US8258264B2 (en) 2003-04-09 2012-09-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing albumin preparation
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
AU2012201036B2 (en) * 2003-12-01 2014-12-04 Novo Nordisk Health Care Ag Virus filtration of liquid factor VII compositions
EP3594222B1 (de) 2003-12-01 2022-08-03 Novo Nordisk Health Care AG Virusfiltrierung von flüssigen faktor-vii-zusammensetzungen
EP1888208B1 (de) * 2004-10-21 2012-11-14 Statens Serum Institut Verfahren mit nanofiltrierung zum erhalnten eines vor infektierenden mitteln sicheren mbl-produkts
WO2008001353A1 (en) * 2006-06-26 2008-01-03 Omrix Biopharmaceuticals Inc. Virus removal by nanofiltration
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
EP2297317A4 (de) 2008-06-04 2011-12-07 Talecris Biotherapeutics Inc Zusammensetzung, verfahren und kit zur herstellung von plasmin
US8158405B2 (en) 2008-06-30 2012-04-17 General Electric Company Process for concentrating and processing fluid samples
US8546127B2 (en) 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
JP5789521B2 (ja) 2009-03-03 2015-10-07 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラスミノーゲンを製造するための組成物、方法およびキット；ならびにそれから製造されるプラスミン
CA2847818A1 (en) * 2011-09-06 2013-03-14 Medimmune, Llc Methods for processing coagulation factors
CN112978859A (zh) * 2021-04-13 2021-06-18 莱特莱德(上海)技术有限公司 一种提取肝素加工废水中肠膜肽的方法
CN116983835B (zh) * 2023-09-28 2024-01-09 杭州华玮生物科技有限公司 一种高强度纤维素除病毒过滤膜及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) * 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin

Also Published As

Publication number Publication date
ES2229481T3 (es) 2005-04-16
EP0979237B1 (de) 2004-11-24
EP0860444A1 (de) 1998-08-26
DK0979237T3 (da) 2005-04-04
EP0979237A1 (de) 2000-02-16
DE69827787D1 (de) 2004-12-30
DE69827787T2 (de) 2006-03-02
WO1998037086A1 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
ATE283277T1 (de) Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
ATE310017T1 (de) Verfahren zur reinigung und isolierung von wasserlöslichen peptiden und proteinen aus pflanzenquellen
KR100998158B1 (ko) 나노여과에 의해서 단백질 용액으로부터 바이러스를 분리제거하는 방법
JPH0660105B2 (ja) 血漿中の肝炎ウイルスの不活性化方法
AU5176701A (en) Process for removing protein aggregate and virus from a protein solution
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
PT88178A (pt) Metodo para a purificacao de virus da hepatite a
ATE327774T1 (de) Verwendung von strukturierten tiefenfiltern zur entfernung von viren
GB1488774A (en) Hepatitis b antigen and method of producing it
EE200200164A (et) Nukleiinhapete puhastamine
KR20020063597A (ko) 다공성막으로 처리되어 바이러스가 제거된 혈장 단백질조성물 및 그 제조 방법
DE60312002D1 (de) Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration
JPH11286453A (ja) 紫外線照射によるタンパク質含有組成物のウイルス不活化処理方法
ATE179428T1 (de) Verfahren zur herstellung von hepatitis antigenen und impfstoffen
ATE452911T1 (de) Virensicherer faktor viii mit niedrigem gehalt an höheren multimeren
AU3252095A (en) Method of producing infection-free pharmaceutical preparations and/or foodstuffs from infectious material, particular material containing prions
ATE323184T1 (de) Verfahren zur herstellung von blutplasmaprodukten durch ausschluss von spenden mit hohen parvo-b19- virenkonzentrationen
SU975795A1 (ru) Способ концентрировани и очистки вирусных суспензий
JP2000319294A (ja) 生物由来高分子溶液精製方法
US20040000482A1 (en) Viral removal
DE69012903D1 (de) Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
Chang et al. Concentrating rotavirus and recombinant enhanced green fluorescent protein from E. coli using a temperature-sensitive hydrogel
AU2003209815A1 (en) Recovery of viruses

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0979237

Country of ref document: EP

RZN Patent revoked